Cosmo N.V.

Fr 56.80As of Sun 8 Nov 2026, 12:00 UTC
SWX:CMHCHealthcare
Country Switzerland
PE (Fwd) •••
TSR 10Y CAGR (7.64%)
Div yield 3.47%
ROE (1.19%)
Drug Manufacturers (General)
Beta (5Y) 1.48
PE TTM —
TSR TTM (14.11%)
Mkt cap Fr 976.4M
ROIC (2.92%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
Fr 55
(3.44%)
(62.62%)
Hold 12|7|3|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.93
0.94
0.95
0.93
17.74%
21.03%
15.62%
1.67%
Revenue€M
76.68
79.48
83.79
88.68
13.26%
10.88%
12.75%
22.58%
Peers (US$1.197B)
Cap (US$)
PE
1.522B
—
875.4M
43.62x
1.306B
14.10x
Capital
TTM
5Y
10Y
Leveragex
5.287
0.501
0.445
EBIT/Intx
0.308
0.176
0.167
Own earn%
56.33
99.70
98.90
Sh yield%
29.16
36.98
32.51
Owners
Insiders/Inst%
14.96
41.63
Short interest%
1.38
SBC / revenue%
1.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
9–13
$1 testx
—
Incr. ROIC%
0